Pasar al contenido principal

MAPEO DE LA RED CORTEZA PREFRONTAL - NUCLEOS DEL RAFE SUBYACENTE A LOS TRASTORNOS DEL ESTADO DE ANIMO EN LA ENFERMEDAD DE PARKINSON PARA IDENTIFICAR CIRCUITOS TERAPEUTICOS

PID2022-141700OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

SAMson: an automated brain extraction tool for rodents using SAM

  • Panadero Soler, Daniel
  • Kotb Selim, Mohamed
  • Martínez-Tazo, Patricia
  • Muñoz-Moreno, Emma
  • Ramos-Cabrer, Pedro
  • López-Larrubia, Pilar
  • De Santis, Silvia
  • Canals, Santiago
  • Pertusa, Antonio
Accurate brain extraction is a critical step in the analysis of rodent head magnetic resonance imaging (MRI) data. However, current methods often encounter difficulties in handling the diverse range of imaging setups, resolutions, and experimental conditions commonly found in this field. SAMson (SAM for Segmentation Of Neuroimages) is an automated tool based on the Segment Anything Model (SAM), designed for robust rodent brain extraction. It integrates a bounding box generator and a mask prediction pipeline, offering fully automated and semi-automated modes to address varying experimental complexities. SAMson has been evaluated using three multi-centre rodent MRI datasets annotated at the pixel level, differing in acquisition parameters, resolution, and animal age groups. The tool demonstrates superior performance to existing methods (BET, RBM, BEN) in terms of segmentation accuracy, with Jaccard indices exceeding 90% across datasets. Its semi-automated mode is particularly effective in challenging scenarios such as low-resolution images and cases requiring refined mask precision. By identifying errors at the individual slice level, SAMson enables rapid and targeted corrections, advancing translational neuroscience by supporting large-scale research workflows. The curated data can be downloaded from https://doi.org/10.20350/digitalCSIC/17000, and the code is available at https://github.com/CanalsLab/SAMson., S.C. acknowledges support from PCI2024-153491 funded by MICIU /AEI /10.130 39/501100011033 and UE, PID2021-128158NB-C21 funded by MICIU/10.13039/ 50110 0011033 and FEDER, UE, CEX2021-001165-S funded by MICIU/AEI /10.13039/50110 0011033 and Excellence Grant CIPROM/2022/15 and INVESTIGO INVEST/2022/396 funded by the Generalitat Valenciana and Next Generation EU. S.D.S. was supported by the the Spanish Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigaci´on (PID2021-128909NA-I00 and CNS2023-14488 ), by the Programs for Centres of Excellence in R&D Severo Ochoa (CEX2021-001165-S), and by the Generalitat Valenciana through a Subvencion para la contratacion de investigadoras e investigadores doctores de excelencia 2021 (CIDEGENT/2021/015) and by a Fundacion Pasqual Maragall Research Programme (2024 call). P.L-L. was funded by grant PID2021-122528OB-I00 funded by MICIU/AEI/10.13039/501100011033/FEDER, UE. Some of the mice used in this study were generated in the project funded by MCIU/AEI/FEDER, UE grants PID2022-141700OB-I00, MCIN/AEI/10.13039/501100011033 and CB/07/09/0034 Center for Networked Biomedical Research on Mental Health (CIBERSAM, Bortolozzi A)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001165-S)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models

  • Miquel-Rio, Lluís
  • Anmella, Gerard
  • Bortolozzi, Analía
In their perspective article Opportunities for advancing miRNA research in psychiatry, Navarro-Flores and Heilbronner highlight the potential of miRNAs as biomarkers and therapeutic targets in psychiatry (Navarro-Flores and Heilbronner, n.d.). Almost 10 years after the first review on the role of miRNAs in psychiatric disorders (Issler and Chen, 2015), the authors provide updated information on new approaches in the investigation of these molecules. They focus on new insights into the regulatory mechanisms of miRNA-dependent transcripts and their downstream functional effects, as well as spatiotemporal dynamics, epidemiological factors (e.g., gender and ethnicity), integration with multi-omics approaches, and the need for bioinformatics standardization and clinical translation. Based on their discussion, we would like to highlight other key areas that we believe are and will continue to be fundamental for the advancement of miRNA research in psychiatry., We thank the support of MCIU/AEI/FEDER, UE grant PID2022-141700OB-I00, MCIN/AEI/10.13039/501100011033; Fundación La Marató TV3 (202207); AGAUR 2021-SGR-01358, Government of Catalonia; and the Translational Research Programme for Brain Disorders, IDIBAPS. We also thank the Spanish Ministry of Health financed by the Instituto de Salud Carlos III (ISCIII) and co-financed by the European Social Fund+ (ESF+) (JR23/00050, MV22/00058, CM21/00017); the ISCIII (PI21/00340, PI21/00169); the Milken Family Foundation (PI046998); the Fundació Clínic per a la Recerca Biomèdica (FCRB) - Pons Bartan 2020 grant (PI04/6549), the Sociedad Española de Psiquiatría y Salud Mental (SEPSM); the Fundació Vila Saborit; and the Societat Catalana de Psiquiatria i Salut Mental (SCPiSM). GA is supported by a Juan Rodés 2023 grant (JR23/00050), a Rio Hortega 2021 grant (CM21/00017) and Acción Estratégica en Salud - Mobility (M-AES) fellowship (MV22/00058), from the Spanish Ministry of Health financed by the Instituto de Salud Carlos III (ISCIII) and co-financed by the Fondo Social Europeo Plus (FSE+)., Peer reviewed